Rating History for Arrowhead Pharma (ARWR) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/21/2026 | Michael E. Ulz | Upgrade | Overweight (Equalweight) |
100.00 (78.00) |
69.51 (82.06) |
18.05% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
